Compare KMDA & HIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | KMDA | HIX |
|---|---|---|
| Founded | 1990 | 1998 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance/Investors Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 458.6M | 376.5M |
| IPO Year | 2013 | 1998 |
| Metric | KMDA | HIX |
|---|---|---|
| Price | $8.70 | $3.92 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $14.00 | N/A |
| AVG Volume (30 Days) | 74.8K | ★ 341.6K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | 2.30% | ★ 13.14% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $14.04 | N/A |
| Revenue Next Year | $7.99 | N/A |
| P/E Ratio | $24.59 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $5.54 | $3.65 |
| 52 Week High | $9.35 | $4.39 |
| Indicator | KMDA | HIX |
|---|---|---|
| Relative Strength Index (RSI) | 49.84 | 24.16 |
| Support Level | $6.69 | N/A |
| Resistance Level | $8.88 | $4.26 |
| Average True Range (ATR) | 0.28 | 0.05 |
| MACD | -0.08 | -0.03 |
| Stochastic Oscillator | 31.87 | 8.82 |
Kamada Ltd is a drug-focused, plasma-derived protein therapeutics company. It is involved in the business of developing, producing, and marketing specialty therapeutics using protein purification proprietary technology. Its product portfolio consists of Glassia, Bramitob, Foster, Ixiaro, Factor-IX, and others. The company has two segments namely, the Proprietary Products segment and the Distribution segment. It derives the majority of its revenue from the Proprietary products segment. The firm categorizes its products in Lung Disease, Vaccines, Haemophilia, Immunoglobulins, Critical care, and Diagnostics.
Western Asset High Income Fund II Inc is a diversified closed-end management investment company. Its investment objective is to maximize current income by investing at least 80% of its net assets and borrowings for investment purposes in high-yield debt securities.